American Gene Technologies® International Inc.

About American Gene Technologies® International Inc.

American Gene Technologies® International Inc. (AGT™) is a private biotechnology company pursuing cures and treatments for infectious diseases, cancers, and monogenic disorders.

AGT™'s emerging gene and cell therapeutics programs are designed to:
✅ Create immunotherapy for HIV disease with gene-modified T cells
✅ Activate innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology
✅ Treat PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation
✅ Advance clinically to provide human proof of concept

For over a decade, AGT™ has developed, tested, and banked thousands of lentiviral vectors that can be adapted to the specific needs of new target diseases. AGT™ has developed gene therapy for diseases using this rapid gene delivery platform.

GENE THERAPIES
AGT™’s platform allows it to pursue clinical “cures” for complex diseases. The company has developed patent-protected gene therapeutics that are breakthroughs in medicine.

*** See our extensive award winning patents on our website ***

HIV/AIDS
Immunotherapy for HIV disease with gene-modified T cells

IMMUNO-ONCOLOGY
Activates innate T cell immunity capable of killing all tumor cells with its vector used in immuno-oncology

PHENYLKETONURIA (PKU)
Treats PKU by bringing a functional gene into cells that express a dysfunctional gene due to mutation

AGT™'s Core Objectives
✔️ Leverage our lentivirus platform to create highly-effective targeted genetic medicines
✔️ Create solutions for patients across a spectrum of infectious diseases, cancers and inherited disorders
✔️ Collaborate with leading medical researchers from around the globe

To learn more and get in touch with American Gene Technologies® Inc., contact us today at https://www.americangene.com/contact-us/

Website	http://www.americangene.com/
Employees	11-50 employees View all American Gene Technologies® International Inc. employees
Industry	Biotechnology
Headquarter	9713 Key West Ave, 500, Rockville, Maryland 20850, US
Founded	2007
Keywords	Gene Therapy, Cell Therapy, Immuno-Oncology, Cancer Therapeutics, Autosomal Disorders, Hiv And Hepatitis-C Viral Therapeutics

Get verified email of American Gene Technologies® International Inc. employees

American Gene Technologies® International Inc. Alternatives

Innovotech Inc.

Biotechnology

Resolution Bioscience

biotechnology

Verastem Oncology

biotechnology

Tocagen Inc.

Biotechnology

ZymoGenetics

Biotechnology

Valentis

biotechnology

Galactic

biotechnology

McMahans Furniture

Biotechnology

Frequently Asked Questions about American Gene Technologies® International Inc.

Who are the decision makers in American Gene Technologies® International Inc.?

The decision makers in American Gene Technologies® International Inc. are Drew Palin, Jeff Galvin, Jeff Galvin, etc. Click to Find American Gene Technologies® International Inc. decision makers emails.

What types of diseases does American Gene Technologies® focus on treating?

American Gene Technologies® specializes in developing gene and cell therapies for a variety of conditions, including infectious diseases, cancers, and monogenic disorders. Their research includes innovative treatments for HIV, Hepatitis-C, and various types of cancer, as well as therapies aimed at autosomal disorders.

How does American Gene Technologies® approach gene therapy?

AGT™ employs cutting-edge gene therapy techniques that involve modifying genes to treat or prevent diseases. This may include delivering therapeutic genes to patients' cells to correct genetic defects or enhance the immune response against cancer. Their approach is rooted in rigorous scientific research and clinical trials to ensure safety and efficacy.

What is the significance of immuno-oncology in AGT™'s research?

Immuno-oncology is a critical area of focus for American Gene Technologies® as it leverages the body's immune system to fight cancer. By developing therapies that enhance immune responses, AGT™ aims to create more effective treatments that can target and destroy cancer cells while minimizing damage to healthy tissues.

Are there any ongoing clinical trials for AGT™'s therapies?

Yes, American Gene Technologies® is actively conducting clinical trials for its gene and cell therapies. These trials are essential for evaluating the safety and effectiveness of their treatments. Interested individuals can find more information about ongoing trials and eligibility criteria on the company’s website or by contacting their clinical research team.

What industries does American Gene Technologies® serve?

AGT™ primarily serves the biotechnology and pharmaceutical industries. Their innovative therapies have the potential to transform treatment options for patients suffering from various diseases, thereby impacting healthcare providers, researchers, and patients alike. The company's work also intersects with academic institutions and research organizations focused on advancing medical science.

How can I stay updated on American Gene Technologies®'s latest developments?

To stay informed about the latest news, research developments, and clinical trial updates from American Gene Technologies®, you can subscribe to their newsletter, follow them on social media platforms, or regularly check their official website. They often publish press releases and updates that provide insights into their ongoing projects and breakthroughs.